Abstract
Alongside analyses of clinical effectiveness, economic evaluation is increasingly being used as a tool to support the adoption of new healthcare technologies, including novel endovascular techniques. Where budget constraints exist, resource allocation decisions are inevitable and an economic evaluation provides an explicit framework from which to assess the relative benefit of alternative interventions. Methods of economic evaluation differ largely in the perspective taken (i.e. cost-effective for whom?), and the measurement and valuation of outcomes.